# KCK Medtech

> KCK Medtech is a Campbell, California investment firm focused on medical device companies. Its evergreen, single-family-sponsored capital supports flexible, long-term investing, while a team of former medical technology operators helps portfolio companies with hiring, development and commercialization.

- **Founded:** 2015
- **Headquarters:** Campbell, United States
- **Products:** Medical device investment capital, Operational portfolio support
- **Notable:** Led Sonex Health’s Series A and September 2023 $40 million Series B., Led Allotex’s July 2023 $30 million Series B first close., KCK Group led RefleXion’s April 2016 $46 million Series B.

## Products & services

- **Medical device investment capital** — Evergreen investment capital for medical device businesses; Greg Garfield has described flexibility across debt and equity, private and public companies, and company stages.
- **Operational portfolio support** — Support with talent identification, operating challenges and product development or commercialization, including contributions from KCK team members when needed.

## Achievements

- Led Sonex Health’s Series A and September 2023 $40 million Series B.
- Led Allotex’s July 2023 $30 million Series B first close.
- KCK Group led RefleXion’s April 2016 $46 million Series B.
- Portfolio company Aerin Medical reported over 200,000 patients treated in March 2026.

## Latest updates

- **2026-10** — Portfolio company Aerin Medical announced preferred RF vendor status with US ENT Partners, whose network includes more than 1,500 physicians and 300 member practices. This is an Aerin partnership, not a direct KCK partnership.
- **2026-07** — Portfolio company RefleXion announced its next-generation platform at AAPM 2026.
- **2026-04** — RefleXion announced expanded Medicare payment for SCINTIX in freestanding centers following a Noridian decision.
- **2026-03** — Aerin Medical announced more than 200,000 patients treated with its nasal-condition technologies.
- **2025-02** — NeuroPace completed repurchase of 5,270,845 shares from KCK Ltd., exhausting that entity’s remaining shareholding.

## Links

- Website: https://www.kckmedtech.com/
- LinkedIn: https://www.linkedin.com/company/kck-medtech/

---

Profile page: https://yespress.io/kck-medtech
Published by YesPress — https://yespress.io
Last updated: 2026-10-27